RT Journal Article
SR Electronic
T1 SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020: a cross-sectional study with short-term follow-up
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.23.20041913
DO 10.1101/2020.03.23.20041913
A1 Kluytmans-van den Bergh, Marjolein F.Q.
A1 Buiting, Anton G.M.
A1 Pas, Suzan D.
A1 Bentvelsen, Robbert G.
A1 van den Bijllaardt, Wouter
A1 van Oudheusden, Anne
A1 van Rijen, Miranda M.L.
A1 Verweij, Jaco J.
A1 Koopmans, Marion P.G.
A1 Kluytmans, Jan A.J.W.
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.23.20041913.abstract
AB COVID-19 is spreading rapidly over the world. On February 27, 2020, the first patient with COVID-19 was reported in the Netherlands, linked to a trip to Northern Italy. In the following weeks, we identified nine Health Care Workers (HCW) of whom eight had no epidemiological link to countries with a high incidence of COVID-19 at that time. This suggested local spread of SARS-CoV-2 in the community and prompted a low-threshold screening in HCWs.Screening was performed in two large teaching hospitals in the southern part of the Netherlands. HCWs who suffered from fever or mild respiratory symptoms were tested for SARS-CoV-2 by RT-PCR on oropharyngeal samples. Structured interviews were conducted to document symptoms.Eighty-six (6.4%) out of 1,353 HCWs were infected with SARS-Cov-2. The median age was 49 years and 15 (17.4%) were male. Most suffered from relatively mild disease. Only 46 (53.5%) HCWs had fever during the course of illness. Seventy-nine (91.9%) HCWs met a case definition of fever and/or coughing and/or shortness of breath. The majority (n=54, 62.8%) reported to have worked while being symptomatic.Within one week after the first case was reported, a substantial proportion of HCWs with fever or respiratory symptoms were proven to be infected with SARS-Cov-2. This observation suggests that there is a relatively high prevalence of mild clinical presentations that may go undetected. The spectrum of symptoms present in HCWs with COVID-19, frequently not including fever, asks for less stringent use of the currently recommended case-definition for suspected COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMKo participates in the RECOVER project that is funded by the European Commission under H2020 call SC1-PHE-CORONAVIRUS-2020. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data analysed are available from the presenting author on reasonable request.